J1725 – Injection, hydroxyprogesterone caproate, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1725
- Long description
- Injection, hydroxyprogesterone caproate, 1 mg
- Short description
- Hydroxyprogesterone caproate
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
INot payable by Medicare- BETOS category
O1EOther drugs- Added
- January 1, 2012
- Last change
- January 1, 2018 – No change
- Termination date
- December 31, 2017
Frequently asked questions
What is HCPCS code J1725?
J1725 is a HCPCS Level II code for injection, hydroxyprogesterone caproate, 1 mg. It was discontinued on December 31, 2017.
Does Medicare cover J1725?
The HCPCS file lists coverage code I: Not payable by Medicare. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1650 – Injection, enoxaparin sodium, 10 mg
- J1652 – Injection, fondaparinux sodium, 0.5 mg
- J1655 – Injection, tinzaparin sodium, 1000 iu
- J1670 – Injection, tetanus immune globulin, human, up to 250 units
- J1675 – Injection, histrelin acetate, 10 micrograms
- J1700 – Injection, hydrocortisone acetate, up to 25 mg
- J1710 – Injection, hydrocortisone sodium phosphate, up to 50 mg
- J1720 – Injection, hydrocortisone sodium succinate, up to 100 mg
- J1726 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730 – Injection, diazoxide, up to 300 mg
- J1736 – Injection, meloxicam (delova), 1 mg
- J1737 – Injection, meloxicam (azurity), 1 mg
- J1738 – Injection, meloxicam, 1 mg
- J1740 – Injection, ibandronate sodium, 1 mg
- J1741 – Injection, ibuprofen, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.